Evidence map›Paper›PMID 36044955›Full record

ArticleBiochimica et biophysica acta. General subjects2022

Extracellular matrix stiffness regulates degradation of MST2 via SCF

Ana Paula Zen Petisco Fiore, Ana Maria Rodrigues, Helder Veras Ribeiro-Filho, Antonio Carlos Manucci, Pedro de Freitas Ribeiro, Mayara Carolinne Silva Botelho, Christine Vogel, Paulo Sergio Lopes-de-Oliveira, Michele Pagano, Alexandre Bruni-Cardoso

Open access · greenAbstract read
In one paragraph

Article in Biochimica et biophysica acta. General subjects, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Targeting ubiquitination in disease and therapy.Signal transduction and targeted therapy · 2025
    Review
  2. Article
  3. Article
  4. Cortical tension promotes Kibra degradation via Par-1.Molecular biology of the cell · 2024
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Ana Paula Zen Petisco FioreDepartamento de Bioquímica, Instituto de Química, Universidade de São Paulo, São Paulo 05508-000, Brazil; Department of Biology, New York University, New York, NY 10003, USA.
Ana Maria RodriguesDepartamento de Bioquímica, Instituto de Química, Universidade de São Paulo, São Paulo 05508-000, Brazil.
Helder Veras Ribeiro-FilhoLaboratório Nacional de Biociências, Centro Nacional de Pesquisa em Energia e Materiais, Campinas 13083-970, Brazil.
Antonio Carlos ManucciDepartamento de Bioquímica, Instituto de Química, Universidade de São Paulo, São Paulo 05508-000, Brazil.
Pedro de Freitas RibeiroDepartamento de Bioquímica, Instituto de Química, Universidade de São Paulo, São Paulo 05508-000, Brazil.
Mayara Carolinne Silva BotelhoDepartamento de Bioquímica, Instituto de Química, Universidade de São Paulo, São Paulo 05508-000, Brazil.
Christine VogelDepartment of Biology, New York University, New York, NY 10003, USA.
Paulo Sergio Lopes-de-OliveiraLaboratório Nacional de Biociências, Centro Nacional de Pesquisa em Energia e Materiais, Campinas 13083-970, Brazil.
Michele PaganoDepartment of Biochemistry and Molecular Pharmacology, Howard Hughes Medical Institute, New York University Grossman School of Medicine, New York, NY 10016, USA.
Alexandre Bruni-CardosoDepartamento de Bioquímica, Instituto de Química, Universidade de São Paulo, São Paulo 05508-000, Brazil. Electronic address: brunicar@iq.usp.br.
Universidade de São Paulo · BRBrazilian Center for Research in Energy and Materials · BRHoward Hughes Medical Institute · USLaboratório Nacional de Ciência e Tecnologia do Bioetanol · BRNew York University · US

Funding

F-Box Proteins: Deregulated Cell Cycle Control and Proteolysis in CancerR01CA076584 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI PAGANO, MICHELE · 1998 to 2021
$4.5M
Next generation gene expression analysisR35GM127089 · NIGMS · NEW YORK UNIVERSITY · PI Christine Vogel · 2018 to 2026
$4.0M
Regulation of the cell proliferation by CRL ubiquitin ligases-diversity supplementR35GM136250 · NIGMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI MICHELE PAGANO · 2020 to 2026
$2.7M
Howard Hughes Medical InstituteNCI NIH HHS R01 CA076584NIGMS NIH HHS R35 GM127089NIGMS NIH HHS R35 GM136250
6 · The paper itself

Abstract

The Hippo pathway plays central roles in relaying mechanical signals during development and tumorigenesis, but how the proteostasis of the Hippo kinase MST2 is regulated remains unknown. Here, we found that chemical inhibition of proteasomal proteolysis resulted in increased levels of MST2 in human breast epithelial cells. MST2 binds SCF

Indexed as

beta-Transducin Repeat-Containing ProteinsSerine-Threonine Kinase 3Ubiquitin-Protein LigasesExtracellular MatrixHippo KinasesHumansPhosphorylationProteolysisbeta-Transducin Repeat-Containing ProteinsHippo KinasesSerine-Threonine Kinase 3STK3 protein, humanUbiquitin-Protein LigasesBreast cellsExtracellular matrix stiffnessHippoMST2SCF βTrCPUbiquitinproteasome system

Identifiers

PMID36044955
PMCPMC9926743
OpenAlexW4293652587

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.